Namhae Chemical (025860) — Free Cash Flow Generation Index

Latest as of September 2025: 0.94x

Namhae Chemical (025860) has a Free Cash Flow Generation Index of 0.94x as of September 2025. Free cash flow of ₩116.89 Billion represents 1% of operating cash flow (₩124.52 Billion). Explore 025860 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.94x
Free Cash Flow / Operating CF

Free Cash Flow

₩116.89 Billion
KRW

Operating Cash Flow

₩124.52 Billion
KRW

Capital Expenditures

₩7.63 Billion
KRW

Namhae Chemical Free Cash Flow Generation Index (2001–2024)

Historical FCF Generation Index trend for Namhae Chemical across 12 annual periods. For the full cash flow conversion analysis, see Namhae Chemical cash flow conversion.

Annual Free Cash Flow Generation for Namhae Chemical (2001–2024)

Year-by-year Free Cash Flow Generation Index for Namhae Chemical. Check Namhae Chemical (025860) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2024 0.59x ₩71.15 Billion ₩120.28 Billion ₩49.14 Billion ▲ +157.4%
2023 0.23x ₩23.40 Billion ₩101.86 Billion ₩78.46 Billion ▼ -67.6%
2020 0.71x ₩37.23 Billion ₩52.50 Billion ₩15.14 Billion ▼ -3.2%
2019 0.73x ₩33.19 Billion ₩45.29 Billion ₩12.10 Billion ▲ +220.7%
2018 -0.61x ₩-4.85 Billion ₩7.99 Billion ₩12.84 Billion ▼ -265.6%
2017 0.37x ₩11.27 Billion ₩30.72 Billion ₩19.25 Billion ▼ -77.5%
2016 1.63x ₩92.51 Billion ₩56.69 Billion ₩35.83 Billion ▲ +42.6%
2015 1.14x ₩91.49 Billion ₩79.95 Billion ₩11.54 Billion ▲ +3.1%
2006 1.11x ₩66.83 Billion ₩60.20 Billion ₩6.63 Billion ▼ -54.8%
2004 2.46x ₩15.45 Billion ₩6.29 Billion ₩9.16 Billion ▼ -78.2%
2003 11.27x ₩16.10 Billion ₩1.43 Billion ₩14.67 Billion ▲ +535.8%
2001 1.77x ₩177.20 Billion ₩100.02 Billion ₩77.19 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).